Plants (Jan 2022)

Antioxidation, Anti-Inflammation, and Regulation of <i>SRD5A</i> Gene Expression of <i>Oryza sativa</i> cv. Bue Bang 3 CMU Husk and Bran Extracts as Androgenetic Alopecia Molecular Treatment Substances

  • Chiranan Khantham,
  • Pichchapa Linsaenkart,
  • Tanakarn Chaitep,
  • Pensak Jantrawut,
  • Chuda Chittasupho,
  • Pornchai Rachtanapun,
  • Kittisak Jantanasakulwong,
  • Yuthana Phimolsiripol,
  • Sarana Rose Sommano,
  • Chanakan Prom-u-thai,
  • Sansanee Jamjod,
  • Chaiwat Arjin,
  • Korawan Sringarm,
  • Houda Berrada,
  • Francisco J. Barba,
  • Francisco David Carmona,
  • Wutigri Nimlamool,
  • Warintorn Ruksiriwanich

DOI
https://doi.org/10.3390/plants11030330
Journal volume & issue
Vol. 11, no. 3
p. 330

Abstract

Read online

Androgenetic alopecia (AGA), a hair loss disorder, is a genetic predisposition to sensitive androgens, inflammation, and oxidative stress. Unfortunately, current treatments with synthetic medicines contain a restricted mechanism along with side effects, whereas the bioactive constituents of plant extracts are multifunctional, with fewer side effects. The massive amounts of rice husk and bran are agricultural wastes that may cause pollution and environmental problems. Owing to these rationales, the local rice variety, Bue Bang 3 CMU (BB3CMU), which is grown in northern Thailand, was evaluated for the valuable utilization of rice by-products, husk (BB3CMU-H) and bran (BB3CMU-RB) extracts, for AGA treatment regarding antioxidant, anti-inflammatory, anti-androgenic activities, and the characterization of bioactive compounds. Our study verified that BB3CMU-H had the highest level of polyphenols, contributing to its greater antioxidant activity. Conversely, BB3CMU-RB was the predominant source of tocopherols, resulting in better anti-androgenic activities regarding the downregulation of steroid 5α-reductase genes (SRD5A). Notably, anti-inflammation via the attenuation of nitric oxide productions was observed in BB3CMU-H (0.06 ± 0.13 μM) and BB3CMU-RB (0.13 ± 0.01 μM), which were significantly comparable to diclofenac sodium salt (0.13 ± 0.19 μM). Therefore, the combination of BB3CMU-H and BB3CMU-RB could be utilized in cosmeceutical and pharmaceutical applications for AGA patients.

Keywords